US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Statera Biopharma Inc

0.0004

+0.0002100.00%

Volume:205.00

Turnover:0.08

Market Cap:29.03K

PE:0.00

High:0.0004

Open:0.0004

Low:0.0004

Close:0.0002

52wk High:0.0133

52wk Low:0.0000

Shares:72.58M

Float Shares:63.88M

Volume Ratio:0.17

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8100

EPS(LYR):-2.9009

ROE:-286.94%

ROA:-23.85%

PB:-0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Tivic Health Reports Q3 2025 Results and Advances Entolimod Development

Tivic Health Receives FDA Approval for Two Investigational New Drug Applications for Entolimod™ to Treat Acute Radiation Syndrome and Advanced Cancers

Tivic Health Systems Inc. Announces Amended Exclusive License Agreement with Statera Biopharma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/STAB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"STAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STAB\",,,,,undefined,":{"symbol":"STAB","market":"US","secType":"STK","nameCN":"Statera Biopharma Inc","latestPrice":0.0004,"timestamp":1770733820377,"preClose":0.0002,"halted":0,"volume":205,"delay":15,"changeRate":1,"floatShares":63878970,"shares":72584254,"eps":-1.81,"marketStatus":"Trading","change":0.0002,"latestTime":"02-10 09:30:20 EST Delay","open":0.0004,"high":0.0004,"low":0.0004,"amount":0.082,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.81,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"exchange":"EXPERT","adjPreClose":0.0002,"volumeRatio":0.174708},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STAB\",,,,,undefined,":{"symbol":"STAB","floatShares":63878970,"roa":"-23.85%","roe":"-286.94%","lyrEps":-2.900878,"volumeRatio":0.174708,"shares":72584254,"dividePrice":0,"high":0.0004,"amplitude":0,"preClose":0.0002,"low":0.0004,"week52Low":0.000001,"pbRate":"-0.00","psRate":"0.01","week52High":0.0133,"institutionHeld":0,"latestPrice":0.0004,"eps":-1.81,"divideRate":0,"volume":205,"delay":15,"ttmEps":-1.81,"open":0.0004,"prevYearClose":0.0003,"prevWeekClose":0.0002,"prevMonthClose":0.0001,"prevQuarterClose":0.0003,"fiveDayClose":0.0001,"twentyDayClose":0.0002,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/STAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-10-28","symbol":"STAB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1666929600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-03-31","symbol":"STAB","fiscalQuarterEnding":"2021/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1648699200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-08-16","symbol":"STAB","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629086400000,"reportTimeType":"","actualEps":-0.04},{"market":"US","date":"2017-11-14","symbol":"STAB","fiscalQuarterEnding":"2017/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1510635600000,"reportTimeType":"","actualEps":-0.11},{"market":"US","date":"2017-08-14","symbol":"STAB","fiscalQuarterEnding":"2017/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1502683200000,"reportTimeType":"","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"STAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"STAB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/STAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"STAB","date":"2023-01-10","current":-0.052976,"percent":0.99375,"low":-10.097272,"twenty":-2.78205,"median":-0.488732,"eighty":-0.225462,"high":-0.048333,"avg":-1.858727,"sd":2.603042,"marketCap":4864908},"quantilePoints":[{"date":"2021-09-03","current":-7.672187,"twenty":-7.404269,"median":-7.002393,"eighty":-6.600517,"marketCap":128374080},{"date":"2021-09-10","current":-8.808807,"twenty":-8.808807,"median":-8.128865,"eighty":-7.245954,"marketCap":147392462},{"date":"2021-09-17","current":-6.51527,"twenty":-8.585543,"median":-7.245954,"eighty":-6.596457,"marketCap":109016084},{"date":"2021-09-24","current":-5.520727,"twenty":-7.672187,"median":-6.606606,"eighty":-5.94696,"marketCap":92374999},{"date":"2021-10-01","current":-4.688559,"twenty":-7.672187,"median":-6.474676,"eighty":-5.013307,"marketCap":78450827},{"date":"2021-10-08","current":-3.427199,"twenty":-7.245954,"median":-5.855624,"eighty":-4.647965,"marketCap":74715073},{"date":"2021-10-15","current":-7.390787,"twenty":-7.390787,"median":-5.94696,"eighty":-4.647965,"marketCap":91151276},{"date":"2021-10-22","current":-10.071248,"twenty":-8.223552,"median":-6.494973,"eighty":-4.688559,"marketCap":124209662},{"date":"2021-10-29","current":-9.290531,"twenty":-8.808807,"median":-6.616754,"eighty":-4.749449,"marketCap":114581006},{"date":"2021-11-05","current":-9.368603,"twenty":-9.056316,"median":-7.215509,"eighty":-4.911823,"marketCap":115543872},{"date":"2021-11-12","current":-7.826118,"twenty":-9.264507,"median":-7.390787,"eighty":-5.013307,"marketCap":130949721},{"date":"2021-11-19","current":-3.872614,"twenty":-9.056316,"median":-7.215509,"eighty":-4.647965,"marketCap":111692409},{"date":"2021-11-26","current":-3.716819,"twenty":-8.993859,"median":-6.821603,"eighty":-4.112983,"marketCap":107199036},{"date":"2021-12-03","current":-2.78205,"twenty":-8.957426,"median":-6.51527,"eighty":-3.788039,"marketCap":80238800},{"date":"2021-12-10","current":-2.570614,"twenty":-8.83749,"median":-6.139779,"eighty":-3.616159,"marketCap":74140651},{"date":"2021-12-17","current":-2.615127,"twenty":-8.808807,"median":-5.703398,"eighty":-3.439661,"marketCap":75424472},{"date":"2021-12-23","current":-2.53723,"twenty":-8.674849,"median":-5.344988,"eighty":-2.931168,"marketCap":73177785},{"date":"2021-12-31","current":-2.492717,"twenty":-8.462034,"median":-4.830636,"eighty":-2.620298,"marketCap":71893964},{"date":"2022-01-07","current":-2.092102,"twenty":-8.286009,"median":-4.647965,"eighty":-2.555035,"marketCap":60339577},{"date":"2022-01-14","current":-2.114358,"twenty":-8.223552,"median":-4.250972,"eighty":-2.492717,"marketCap":60981488},{"date":"2022-01-21","current":-2.070738,"twenty":-8.171504,"median":-3.850358,"eighty":-2.448204,"marketCap":59723408},{"date":"2022-01-28","current":-1.576584,"twenty":-7.986506,"median":-3.805844,"eighty":-2.354727,"marketCap":45471231},{"date":"2022-02-04","current":-1.576584,"twenty":-7.764546,"median":-3.696635,"eighty":-2.252348,"marketCap":45471231},{"date":"2022-02-11","current":-1.234044,"twenty":-7.672187,"median":-3.614137,"eighty":-2.185578,"marketCap":35591827},{"date":"2022-02-18","current":-1.150259,"twenty":-7.580306,"median":-3.479644,"eighty":-2.101004,"marketCap":33175330},{"date":"2022-02-25","current":-0.921506,"twenty":-7.432145,"median":-3.349445,"eighty":-2.029783,"marketCap":26577729},{"date":"2022-03-04","current":-0.948266,"twenty":-7.381945,"median":-2.837691,"eighty":-1.675415,"marketCap":27349509},{"date":"2022-03-11","current":-0.842268,"twenty":-7.326452,"median":-2.65282,"eighty":-1.614234,"marketCap":24292359},{"date":"2022-03-18","current":-0.820315,"twenty":-7.233776,"median":-2.570614,"eighty":-1.378629,"marketCap":23659199},{"date":"2022-03-25","current":-0.598514,"twenty":-7.153342,"median":-2.553922,"eighty":-1.223652,"marketCap":17262121},{"date":"2022-04-01","current":-0.546311,"twenty":-6.944512,"median":-2.526101,"eighty":-1.154052,"marketCap":15756500},{"date":"2022-04-08","current":-0.466186,"twenty":-6.612695,"median":-2.487153,"eighty":-1.007915,"marketCap":13445547},{"date":"2022-04-14","current":-0.591404,"twenty":-6.596457,"median":-2.448204,"eighty":-0.948266,"marketCap":17057037},{"date":"2022-04-22","current":-0.453352,"twenty":-6.51527,"median":-2.392563,"eighty":-0.896176,"marketCap":13075394},{"date":"2022-04-29","current":-0.659216,"twenty":-6.474676,"median":-2.331358,"eighty":-0.831876,"marketCap":19012844},{"date":"2022-05-06","current":-0.533131,"twenty":-6.332599,"median":-2.259025,"eighty":-0.771992,"marketCap":15376343},{"date":"2022-05-13","current":-0.396466,"twenty":-5.94696,"median":-2.236768,"eighty":-0.598514,"marketCap":11434717},{"date":"2022-05-20","current":-0.438263,"twenty":-5.764289,"median":-2.181127,"eighty":-0.584813,"marketCap":12640214},{"date":"2022-05-27","current":-0.419706,"twenty":-5.703398,"median":-2.116079,"eighty":-0.544751,"marketCap":12104994},{"date":"2022-06-03","current":-0.422828,"twenty":-5.557261,"median":-2.08142,"eighty":-0.532923,"marketCap":12195031},{"date":"2022-06-10","current":-0.43358,"twenty":-5.380136,"median":-2.025332,"eighty":-0.502815,"marketCap":12505159},{"date":"2022-06-17","current":-0.416237,"twenty":-5.079643,"median":-1.717771,"eighty":-0.488697,"marketCap":12004952},{"date":"2022-06-24","current":-0.419532,"twenty":-4.952417,"median":-1.670709,"eighty":-0.469273,"marketCap":12099992},{"date":"2022-07-01","current":-0.494282,"twenty":-4.814399,"median":-1.623647,"eighty":-0.464868,"marketCap":14255881},{"date":"2022-07-08","current":-0.462023,"twenty":-4.725093,"median":-1.576584,"eighty":-0.464209,"marketCap":13325497},{"date":"2022-07-15","current":-0.39109,"twenty":-4.672321,"median":-1.439626,"eighty":-0.46237,"marketCap":11279653},{"date":"2022-07-22","current":-0.396119,"twenty":-4.578193,"median":-1.247034,"eighty":-0.440275,"marketCap":11424713},{"date":"2022-07-29","current":-0.35727,"twenty":-4.41567,"median":-1.201829,"eighty":-0.435488,"marketCap":10304251},{"date":"2022-08-05","current":-0.398894,"twenty":-4.266552,"median":-1.169225,"eighty":-0.429175,"marketCap":11504746},{"date":"2022-08-19","current":-0.44468,"twenty":-4.112983,"median":-1.094273,"eighty":-0.428863,"marketCap":12825291},{"date":"2022-08-22","current":-0.420573,"twenty":-4.052891,"median":-1.082322,"eighty":-0.426366,"marketCap":12130004},{"date":"2022-08-31","current":-0.329521,"twenty":-3.872614,"median":-1.052185,"eighty":-0.422828,"marketCap":9503921},{"date":"2022-09-06","current":-0.301425,"twenty":-3.863711,"median":-1.024516,"eighty":-0.422828,"marketCap":8693586},{"date":"2022-09-16","current":-0.307148,"twenty":-3.828101,"median":-0.974246,"eighty":-0.419706,"marketCap":8858654},{"date":"2022-09-23","current":-0.279573,"twenty":-3.828101,"median":-0.948266,"eighty":-0.416237,"marketCap":8063326},{"date":"2022-09-30","current":-0.221126,"twenty":-3.810295,"median":-0.897085,"eighty":-0.415266,"marketCap":6377631},{"date":"2022-10-07","current":-0.404817,"twenty":-3.734624,"median":-0.858506,"eighty":-0.412075,"marketCap":11675572},{"date":"2022-10-14","current":-0.08295,"twenty":-3.716819,"median":-0.831876,"eighty":-0.401322,"marketCap":8448553},{"date":"2022-10-21","current":-0.076975,"twenty":-3.684524,"median":-0.790243,"eighty":-0.398859,"marketCap":7839970},{"date":"2022-10-28","current":-0.072429,"twenty":-3.628622,"median":-0.753417,"eighty":-0.394731,"marketCap":7555878},{"date":"2022-11-04","current":-0.065564,"twenty":-3.614643,"median":-0.628865,"eighty":-0.384811,"marketCap":6635308},{"date":"2022-11-10","current":-0.055137,"twenty":-3.586097,"median":-0.592271,"eighty":-0.381238,"marketCap":5580054},{"date":"2022-11-18","current":-0.059138,"twenty":-3.536868,"median":-0.584813,"eighty":-0.37274,"marketCap":5430827},{"date":"2022-11-25","current":-0.072619,"twenty":-3.487017,"median":-0.551167,"eighty":-0.366358,"marketCap":6668750},{"date":"2022-12-02","current":-0.073273,"twenty":-3.436546,"median":-0.54345,"eighty":-0.357964,"marketCap":6728878},{"date":"2022-12-09","current":-0.069047,"twenty":-3.364996,"median":-0.533131,"eighty":-0.319635,"marketCap":6340779},{"date":"2022-12-16","current":-0.064702,"twenty":-3.271691,"median":-0.522725,"eighty":-0.301772,"marketCap":5941747},{"date":"2022-12-23","current":-0.059523,"twenty":-2.993486,"median":-0.503994,"eighty":-0.285469,"marketCap":5466189},{"date":"2022-12-30","current":-0.053869,"twenty":-2.86885,"median":-0.494282,"eighty":-0.260426,"marketCap":4946901},{"date":"2023-01-06","current":-0.053571,"twenty":-2.804306,"median":-0.491507,"eighty":-0.225462,"marketCap":4919570},{"date":"2023-01-10","current":-0.052976,"twenty":-2.78205,"median":-0.488732,"eighty":-0.225462,"marketCap":4864908}],"updateTime":1770739509088},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"STAB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583168421","title":"Tivic Health Reports Q3 2025 Results and Advances Entolimod Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2583168421","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583168421?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:30","pubTimestamp":1763155834,"startTime":"0","endTime":"0","summary":"Tivic Health Systems Inc. announced its financial results for the third quarter and nine months ended September 30, 2025. The company reported continued progress in its strategic transformation and advancement of its biologics pipeline. During the quarter, Tivic completed the transfer of two Investigational New Drug  applications from Statera Biopharma, enabling the company to conduct clinical trials in neutropenia and lymphocyte exhaustion, and to explore Entolimod's anti-tumor activity for potential cancer-related indications. The company also finalized cell line verification, a critical step to enable Current Good Manufacturing Practices , required before filing a biologics license application  with the U.S. Food & Drug Administration. Tivic advanced the wind down of its consumer health technology business, discontinued significant resource allocation to ClearUP sales, and wrote off related inventory during the quarter. The company launched a new corporate website reflecting its upd","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL9HQrzH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TIVC","STAB","BK4139"],"gpt_icon":0},{"id":"2560105142","title":"Tivic Health Receives FDA Approval for Two Investigational New Drug Applications for Entolimod™ to Treat Acute Radiation Syndrome and Advanced Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2560105142","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560105142?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:31","pubTimestamp":1755693066,"startTime":"0","endTime":"0","summary":"Tivic Health Receives FDA Approval for Two Investigational New Drug Applications for Entolimod to Treat Acute Radiation Syndrome and Advanced Cancers. Tivic Health Systems Inc. has announced the receipt of two investigational new drug  applications for their lead candidate, Entolimod, from Statera Biopharma. These INDs are aimed at the treatment of acute radiation syndrome  and advanced cancers. The transfer of these applications facilitates Tivic's engagement with the FDA to advance Entolimod along its regulatory pathway. This development enables the pursuit of clinical trials addressing conditions such as neutropenia and lymphocyte exhaustion. Tivic's CEO, Jennifer Ernst, emphasized the company's immediate focus on Entolimod's application for acute radiation syndrome, while also exploring its potential anti-tumor effects in advanced cancer scenarios.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL4HZTRK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STAB","TIVC","BK4082","BK4139"],"gpt_icon":0},{"id":"2546122570","title":"Tivic Health Systems Inc. Announces Amended Exclusive License Agreement with Statera Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2546122570","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546122570?lang=en_us&edition=fundamental","pubTime":"2025-06-26 04:32","pubTimestamp":1750883526,"startTime":"0","endTime":"0","summary":"Tivic Health Systems Inc. has announced a new Amended and Restated Exclusive License Agreement with Statera Biopharma, Inc., which supersedes the previous agreement signed earlier this year. The new agreement maintains similar terms to the original, but introduces key changes, notably allowing Tivic the option to pay royalties in cash or securities. This agreement continues to grant Tivic an exclusive worldwide license to Statera's proprietary Toll-like Receptor 5 agonist program, particularly for Acute Radiation Syndrome, with options for additional indications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tivic Health Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gatheri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL7VXnSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","STAB","TIVC"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}